Something inauspicious is happening with the biotechs and pharma, especially with ALXN.
Selling ALXN and Buying ACAD and BMRN...thats where you can get in before another big RUN UP on these. ACAD heading for $40 and BMRN heading for $90.
nah, just Roche releasing some nonsense about what direction they are headed.................which sounded like they really don't know for sure.
They know for sure. Just trying to figure what to offer.